ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.730,77
0,37%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Biotech Acquisition Company (BIOT)

  7. Biotech Acquisition Company (BIOT) News

BIOT

Biotech Acquisition (BIOT)

Biotech Acquisition Company
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BIOT
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202323h02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:BIOTBiotech Acquisition Company
13/02/202320h12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOTBiotech Acquisition Company
02/02/202322h56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BIOTBiotech Acquisition Company
02/02/202312h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
27/01/202319h19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
25/01/202318h14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
11/01/202315h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
04/01/202323h51PR Newswire (US)Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension AmendmentNASDAQ:BIOTBiotech Acquisition Company
04/01/202321h20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOTBiotech Acquisition Company
22/11/202212h05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
14/11/202219h44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BIOTBiotech Acquisition Company
11/10/202222h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
22/08/202222h06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
01/08/202214h00Business WireBlade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology ConferenceNASDAQ:BIOTBiotech Acquisition Company
17/06/202222h06Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:BIOTBiotech Acquisition Company
17/06/202222h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
13/06/202214h06PR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination AgreementNASDAQ:BIOTBiotech Acquisition Company
03/06/202212h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
03/06/202212h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
03/06/202202h58PR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
31/05/202214h18Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
31/05/202214h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
31/05/202213h30PR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
24/05/202215h30Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
24/05/202215h13PR Newswire (US)Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.NASDAQ:BIOTBiotech Acquisition Company
23/05/202222h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
19/05/202222h31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
18/05/202222h21Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
18/05/202222h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
18/05/202215h01Business WireBlade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International ConferenceNASDAQ:BIOTBiotech Acquisition Company
 Showing the most relevant articles for your search:NASDAQ:BIOT

Kürzlich von Ihnen besucht

EU
7892T
7892T
XE
AJ91
Doccheck Aktiengesellsch...
EU
FRSG00014SW7
SG Issuer Sg Issuer Mc A...
BIT
UB48HX
Unicredit Bank
BIT
UC3X89
Unicredit Bank
TSXV
NEL.UN
Nobel Real Estate Investment
BIT
UC6THU
Unicredit Bank
NASDAQ
HEMO
Hemosense
DBI
D4YH
Inav Db Xtrackers MSCI M...
USOTC
RSLES
RSE Archive (GM)
ASX
SWR
FX
GBPSCR
Sterling vs SCR
LSE
87ZL
Swedbank Non
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten